Salma M. Aldallal. (2023). Ofatumumab as an Emerging Treatment Option for Chronic Lymphocytic Leukaemia Patients. Research Highlights in Disease and Health Research Vol. 2, 10–24. https://doi.org/10.9734/bpi/rhdhr/v2/9253F